You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. High Power III-Nitride Heterojunction Field-Effect Effect Transistor Development

    SBC: III-N Technology, Inc            Topic: N/A

    The research proposed here is built on the recent successful fabrication of metal oxide semiconductor heterjunction field effect transistors (MOS-HFETs) based on AlGaN/GaN heterostructures with very high drain-current-driving and gate-control capabilitiesas well as unprecedented high breakdown voltages by the P.I.s research group at Kansas State University. III-nitride HFETs have great promises i ...

    SBIR Phase I 2003 Department of DefenseMissile Defense Agency
  2. Friction-Reducing Bandage to Prevent Skin Breakdown

    SBC: ADVANCED WOUND SYSTEMS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Pressure ulcers affect approximately 1.7 million patients in the U.S. The overall cost to the healthcare industry for treating pressure ulcers in the U.S. is estimated to exceed $7 billion, and it is well established that the cost of preventing a pressure ulcer is significantly less than its treatment. Skin breakdown is frequently seen in individuals with bot ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  3. Microcontact printer for ophthalmic tissue engineering

    SBC: ALCES Technology, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): This project will demonstrate a prototype microcontact printing aligner for use in ophthalmic tissue engineering. The performance of the microcontact printing aligner will be refined and validated by experiments conducted in collaboration with the Stanford Ophthalmic Tissue Engineering Laboratory. Functioning much like traditional rubber-stamping methods, micro ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  4. Aging Resistant Ceramics for Total Hip Arthroplasty

    SBC: SINTX TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Zirconia bio-ceramics (e.g. Prozyr) have the highest toughness and strength compared to other bio-ceramics such as alumina (e.g. Biolox) or zirconia-toughened alumina (Biolox-Delta). However, as highlighted by the recent recall of St. Gobain zirconia heads, a critical need remains to develop bio-ceramics with both significantly reduced wear characteristics and ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  5. Ultraviolet Light Devices for Vitamin D

    SBC: APOLLO LIGHT SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Vitamin D deficiency is now recognized as a significant health problem for middle-aged and older adults. Vitamin D deficiency exacerbates osteoporosis and causes the bone disease, osteomalacia. Vitamin D deficiency increases risk of skeletal fractures. It is well known that the ultraviolet B portion of the solar spectrum is responsible for the cutaneous product ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  6. Portable Signal Identification Training

    SBC: APPLIED SIGNAL TECHNOLOGY            Topic: N/A

    A unique approach to the problem of portable signal identification training (PSIT) is proposed through the use of an integrated signals database, training software, and the re-use of operator interface software. Two training scenarios are addressed:standalone training mode and transmit training mode. The proposed approach is based entirely on COTS hardware. The approach also minimizes the hardw ...

    SBIR Phase I 2003 Department of DefenseSpecial Operations Command
  7. SBIR Phase I: The Use of Halophytic Plants for the Bioremediation of Coal Bed Methane Discharge Waters

    SBC: AquaMatrix International, Inc.            Topic: N/A

    This Small Business Innovation Research Phase 1 project plans to use halophytic plants for the bioremediation of coal bed methane (CBM) discharge water. CBM discharge is widely viewed as an environmental liability. Indiscriminant surface discharge causes salination of soils. The drilling companies are therefore in urgent need for an acceptable discharge process. The hypothesis for the proposed wor ...

    SBIR Phase I 2003 National Science Foundation
  8. Motion Planning for Omni-Directional Vehicles

    SBC: AUTONOMOUS SOLUTIONS INC            Topic: N/A

    Intelligent, maneuverable, autonomous vehicles will play a critical role in future Army systems.Key to the success of these systems will be their ability to quickly reach goal locations by traversing through unknown, unstructured or even de-structured environments. This proposal addresses how Omni-directional capability can be best exploited throughcustomized planning and control. A hierarchical p ...

    SBIR Phase I 2003 Department of DefenseArmy
  9. Inhibition of Androgen Receptor to treat Prostate Cancer

    SBC: Avi Biopharma, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Prostate cancer is the second leading cause of cancer death in US men. Prostate cancer is highly dependent on androgen stimulation mediated through the androgen receptor (AR) for growth and proliferation. For those with advanced PCa, androgen ablation remains the foundation of therapy. Current methods of androgen ablation focus on diminishing circulating and ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  10. Antisense Morpholino Oligomers to Treat Retinopathy

    SBC: Avi Biopharma, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The broad, long-term objectives of the application are to develop antisense inhibitors of retinopathy and document their mechanism(s) of action. Retinopathy is a significant cause of eye disease and has a major impact on development, learning, communicating, working, health, and quality of life for affected individuals. This application focuses on the inhibitio ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government